Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Verve Therapeutics Inc (NQ: VERV ) 4.670 +0.070 (+1.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Verve Therapeutics Inc < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Expert Ratings for Verve Therapeutics August 29, 2023 Via Benzinga Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss August 10, 2023 The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline. Via Benzinga Topics ETFs Economy Exposures Interest Rates Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results August 10, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics to Present at the Canaccord 43rd Annual Growth Conference August 03, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics's Return On Capital Employed Insights March 08, 2023 Via Benzinga Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD July 21, 2023 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) is not even as good as Danaher Corporation (NYSE: DHR). Via Benzinga Cathie Wood Is Buying This Biotech, but Here's Why I'm Not July 13, 2023 The risks are too high, and it'll take a while for them to be addressed. Via The Motley Fool Cathie Wood Buys More Meta Shares As Mark Zuckerberg Goes All-In On Twitter Rivalry July 07, 2023 Via Benzinga Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday July 03, 2023 Via Benzinga Verve Therapeutics Gains 20.74% In June as Ark Funds Invest June 30, 2023 Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June. Via MarketBeat 5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More June 15, 2023 Via Benzinga Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results June 15, 2023 U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,... Via Benzinga Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million June 15, 2023 Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A. Via Investor's Business Daily Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday June 15, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to... Via Benzinga Verve Therapeutics to Participate in the 2023 Jefferies Healthcare Conference June 01, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day May 23, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results May 15, 2023 From Verve Therapeutics Via GlobeNewswire Why These 3 Nasdaq Stocks Were Glowing Green This Week May 11, 2023 These three biopharmaceutical stocks rocketed higher this week. Via The Motley Fool Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference May 09, 2023 From Verve Therapeutics Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 April 13, 2023 Via Benzinga Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday April 13, 2023 U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global April 06, 2023 Via Benzinga Verve Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day March 27, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates March 03, 2023 From Verve Therapeutics Via GlobeNewswire Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results March 02, 2023 From Verve Therapeutics Via GlobeNewswire Better Buy: Beam Therapeutics or Intellia Therapeutics? February 22, 2023 The two clinical-stage gene-editing companies have good long-term prospects. Via The Motley Fool 3 Deeply Undervalued Stocks That Could Double Your Money February 15, 2023 These cutting-edge biotech stocks hold tremendous upside potential. Via The Motley Fool Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia February 14, 2023 From Verve Therapeutics Via GlobeNewswire Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics February 01, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 February 01, 2023 Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.